Understanding Risk Perception, Behaviour, and Attitudes Related to Other New Tobacco Products Among Youth

June 5, 2020 updated by: Dr. LI William Ho Cheung, The University of Hong Kong

Helping Youth to Quit Smoking by Understanding Their Risk Perception, Behaviour, and Attitudes Related to Electronic Cigarettes and Other New Tobacco Products

To understand the risk perception, behaviour, and attitudes related to electronic cigarettes and other tobacco products among youth.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Phase I Individual qualitative interviews will be conducted to understanding the needs and concerns of youth smokers of e-cigarette or other new tobacco products, including their risk perceptions, and the behaviour, attitudes, and experiences related to these products.

Phase II The findings from the interview in phase I will guide the development of a structure questionnaire for a cross-sectional survey to further explore the behaviour, attitudes, and experiences related to e-cigarette or other new tobacco products among youth.

The findings of this study have important implications for research and clinical practice. Understanding how youth smokers perceive the risks of using e-cigarette and other new tobacco products, and their behaviour, attitudes, experiences related to smoking to help them achieve smoking abstinence. Moreover, the results of this study can understand the misconceptions about e-cigarette and other new tobacco product among youth, increase their perception of the risks of continued smoking and benefits of quitting.

Study Type

Observational

Enrollment (Anticipated)

390

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Hong Kong
    • Pokfulam
      • Hong Kong, Pokfulam, Hong Kong
        • Recruiting
        • The University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 25 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Youth smokers

Description

Inclusion Criteria:

  • Youth smokers who contacted the Youth Quitline will be eligible to be included in this study if they (1) are ethnic Chinese; (2) are aged ≤ 25 years; (3) are ever user of e-cigarette or any new tobacco products; and (4) spoke Cantonese.

Exclusion Criteria:

  • psychologically or physically unable to communicate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Youth smokers
Participants of Youth Quitline
Behavioral: Individual qualitative interview
Individual interviews will be conducted to understanding the needs and concerns of youth smokers of e-cigarette or other new tobacco products, including their risk perceptions, and the behaviour, attitudes, and experiences related to these tobacco products.
Behavioral: cross-sectional survey study
structured questionnaire will be constructed for a cross-sectional survey to further explore the behaviour, attitudes, and experiences related to electronic cigarettes or other new tobacco products among youth.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Smoking behaviors in phase I
Time Frame: Baseline
the behaviour, attitudes, and experiences related to electronic cigarettes and other new tobacco products among youth in individual qualitative interview (Phase I)
Baseline
Smoking behaviors in phase II
Time Frame: Baseline
the behaviour, attitudes, and experiences related to electronic cigarettes and other new tobacco products among youth in structured questionnaires (Phase II)
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2020

Primary Completion (Anticipated)

May 1, 2021

Study Completion (Anticipated)

May 1, 2022

Study Registration Dates

First Submitted

June 2, 2020

First Submitted That Met QC Criteria

June 2, 2020

First Posted (Actual)

June 4, 2020

Study Record Updates

Last Update Posted (Actual)

June 9, 2020

Last Update Submitted That Met QC Criteria

June 5, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • other tobacco products

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The relevant anonymized patient level data, full dataset, technical appendix, and statistical code are available on reasonable request. The approval from the Principal Investigator for the purpose of data use is required.

IPD Sharing Time Frame

After the project is completed and the results of the project has been published.

IPD Sharing Access Criteria

Request could be sent to Principal Investigator (william3@hku.hk)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Individual qualitative interview

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe